Citi tells investors it’s time to sell Moderna after 600%-plus stock gains

Citi tells investors it’s time to sell Moderna after 600%-plus stock gains Citi tells investors it’s time to sell Moderna after 600%-plus stock gains Biotech can’t generate the revenue that investors expect, says Wall Street firm Moderna was the target of a sell recommendation by Citi. . Fallon/ After rallying almost seven-fold this year, Citi is now advising clients it’s time to get out of Moderna. Its healthcare team, led by global head Geoff Meacham, has downgraded the pioneering biotech play to sell from hold as it struggles to justify the valuations and assesses that some of the more optimistic sales assumptions are unrealistic.

While Citi has significantly increased the target price from $60 to $80 by refining its sales and operational expense assumptions, this still falls a long way short of the closing price of $203.46 in New York on Tuesday. Copyright ©2026 MarketWatch, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 Jules Rimmer is a markets reporter in London.

Rimmer spent more than 30 years as a trader and stockbroker, starting at Salomon Brothers in the “Liar's Poker” era, taking in ING Barings, Jefferies and ending it in emerging markets at Investec. He hung up his headset and pivoted to journalism in 2021. There’s a new Wall Street ‘TACO’ index — and this one is saying it’s time for Trump to strike a deal One group of funds is holding up the stock market.

Barclays says oil prices have to fall to drive a year-end rally. Boeing was at risk of losing all fighter-jet production altogether. Now the stock is up on a new Navy contract.

Why Tuesday was one of the most disturbing days for markets in recent memory, according to a Goldman Sachs pro He’s been badmouthing Treasury bonds since 2020, but now ‘the big fat cushion’ of 5.25% yields is turning this strategist bullish Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time.

Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.